Contact
 

Stefano Bertozzi, director of HIV and TB programs at The Gates Foundation, talks about what's to come for HIV. The RV144 HIV vaccine trial results “really reinvigorated the whole area of searching for an HIV vaccine,” he says, adding, “we hope...

The Enterprise Council met via teleconference on 7 December 2010.  Minutes from the meeting are below.

The Global HIV Vaccine Enterprise is accepting applications for its Let’s Talk HIV Prevention series from individuals and organizations around the world interested in hosting a community event to raise awareness of the exceptional...

The European and Developing Countries Clinical Trials Partnership (EDCTP) released its January newsletter, which includes updates on governance, grant opportunities and other selected projects.  The newsletter is available...

The Guardian reported that wealthy publishers of the world's most important medical journals are accused of destroying an agreement with the World Health Organization to allow medics in poor countries to get online access for free. Several major...

The CAPRISA 004 study of tenofovir gel for women published in Science in July and the iPrEx study of pre-exposure...

Inovio Pharmaceuticals today announced the publication of a scientific paper in the medical journal Vaccine that highlights the positive preclinical trial results from the company's novel DNA vaccine targeting HIV Clade C. The vaccine candidate...

AVAC released the first issue of Px Wire for 2011, which takes inventory of the regulatory, trial-planning and scientific agenda-setting steps that are being taken with respect to recent positive trial...

Seventeen major health research funding agencies from around the world, pledged to work together to support "timely and responsible" sharing of data gathered during studies on health, Reuters reported yesterday. Read the full story...

The Global HIV Vaccine Enterprise and the OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation), in close collaboration with the Brazilian Ministry of Health (Department of STD, AIDS and Viral Hepatitis and the Oswaldo Cruz...

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account